BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36167770)

  • 41. Genetic variants at HbF-modifier loci moderate anemia and leukocytosis in sickle cell disease in Tanzania.
    Mtatiro SN; Makani J; Mmbando B; Thein SL; Menzel S; Cox SE
    Am J Hematol; 2015 Jan; 90(1):E1-4. PubMed ID: 25263325
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Modifying effect of XmnI, BCL11A, and HBS1L-MYB on clinical appearances: A study on β-thalassemia and hemoglobin E/β-thalassemia patients in Indonesia.
    Rujito L; Basalamah M; Siswandari W; Setyono J; Wulandari G; Mulatsih S; Sofro AS; Sadewa AH; Sutaryo S
    Hematol Oncol Stem Cell Ther; 2016 Jun; 9(2):55-63. PubMed ID: 27009595
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.
    Mtatiro SN; Singh T; Rooks H; Mgaya J; Mariki H; Soka D; Mmbando B; Msaki E; Kolder I; Thein SL; Menzel S; Cox SE; Makani J; Barrett JC
    PLoS One; 2014; 9(11):e111464. PubMed ID: 25372704
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Genetic Modifiers of Sickle Cell Disease: A Genotype-Phenotype Relationship Study in a Cohort of 82 Children on Mayotte Island.
    Muszlak M; Pissard S; Badens C; Chamouine A; Maillard O; Thuret I
    Hemoglobin; 2015; 39(3):156-61. PubMed ID: 25806420
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Meta-analysis of 2040 sickle cell anemia patients: BCL11A and HBS1L-MYB are the major modifiers of HbF in African Americans.
    Bae HT; Baldwin CT; Sebastiani P; Telen MJ; Ashley-Koch A; Garrett M; Hooper WC; Bean CJ; Debaun MR; Arking DE; Bhatnagar P; Casella JF; Keefer JR; Barron-Casella E; Gordeuk V; Kato GJ; Minniti C; Taylor J; Campbell A; Luchtman-Jones L; Hoppe C; Gladwin MT; Zhang Y; Steinberg MH
    Blood; 2012 Aug; 120(9):1961-2. PubMed ID: 22936743
    [No Abstract]   [Full Text] [Related]  

  • 46.
    Gardner K; Fulford T; Silver N; Rooks H; Angelis N; Allman M; Nkya S; Makani J; Howard J; Kesse-Adu R; Rees DC; Stuart-Smith S; Yeghen T; Awogbade M; Sangeda RZ; Mgaya J; Patel H; Newhouse S; Menzel S; Thein SL
    Blood Adv; 2018 Feb; 2(3):235-239. PubMed ID: 29437638
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Original Research: A case-control genome-wide association study identifies genetic modifiers of fetal hemoglobin in sickle cell disease.
    Liu L; Pertsemlidis A; Ding LH; Story MD; Steinberg MH; Sebastiani P; Hoppe C; Ballas SK; Pace BS
    Exp Biol Med (Maywood); 2016 Apr; 241(7):706-18. PubMed ID: 27022141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Association Between Genetic Polymorphisms and Hb F Levels in Heterozygous β-Thalassemia 3.5 kb Deletions.
    Tepakhan W; Kanjanaopas S; Srewaradachpisal K
    Hemoglobin; 2020 Sep; 44(5):338-343. PubMed ID: 32878504
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Association of polymorphisms in the HBG1-HBD intergenic region with HbF levels.
    Hu L; Huang L; Han Y; Jin T; Liu J; Jiang M; Liu X; Li Y; Han W; An B; Huang S
    J Clin Lab Anal; 2020 Jun; 34(6):e23243. PubMed ID: 32068918
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined and differential effects of alpha-thalassemia and HbF-quantitative trait loci in Senegalese hydroxyurea-free children with sickle cell anemia.
    Gueye Tall F; Martin C; Ndour EHM; Renoux C; Ly ID; Connes P; Gueye PM; Diallo RN; Diagne I; Diop PA; Cissé A; Lopez Sall P; Joly P
    Pediatr Blood Cancer; 2019 Oct; 66(10):e27934. PubMed ID: 31322815
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Genetic modifiers of sickle cell anemia in the BABY HUG cohort: influence on laboratory and clinical phenotypes.
    Sheehan VA; Luo Z; Flanagan JM; Howard TA; Thompson BW; Wang WC; Kutlar A; Ware RE;
    Am J Hematol; 2013 Jul; 88(7):571-6. PubMed ID: 23606168
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Correlations between Multiple SNPs and HbF Levels in β-Thalassemia Carriers.
    Xu Q; Huang L; Jin T; Han Y; Liu J; Zhang W; Biao Y; An B; Huang S
    Clin Lab; 2023 Sep; 69(9):. PubMed ID: 37702677
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Fetal hemoglobin in sickle cell anemia: The Arab-Indian haplotype and new therapeutic agents.
    Habara AH; Shaikho EM; Steinberg MH
    Am J Hematol; 2017 Nov; 92(11):1233-1242. PubMed ID: 28736939
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Genetic Modifiers of Sickle Cell Anemia Phenotype in a Cohort of Angolan Children.
    Ginete C; Delgadinho M; Santos B; Miranda A; Silva C; Guerreiro P; Chimusa ER; Brito M
    Genes (Basel); 2024 Apr; 15(4):. PubMed ID: 38674403
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Annotated definition of BCL11A and HMIP-2 haplotypes through the analysis of sicilian β-thalassemia patients with high levels of fetal hemoglobin.
    Buccheri MA; Spina S; Ruberto C; Lombardo T; Labie D; Ragusa AA
    Hemoglobin; 2013; 37(5):423-34. PubMed ID: 23777413
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia.
    Makani J; Menzel S; Nkya S; Cox SE; Drasar E; Soka D; Komba AN; Mgaya J; Rooks H; Vasavda N; Fegan G; Newton CR; Farrall M; Thein SL
    Blood; 2011 Jan; 117(4):1390-2. PubMed ID: 21068433
    [TBL] [Abstract][Full Text] [Related]  

  • 57. rs11886868 and rs4671393 of BCL11A associated with HbF level variation and modulate clinical events among sickle cell anemia patients.
    Chaouch L; Moumni I; Ouragini H; Darragi I; Kalai M; Chaouachi D; Boudrigua I; Hafsia R; Abbes S
    Hematology; 2016 Mar; ():1-5. PubMed ID: 26125973
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Influences of genetic variation on fetal hemoglobin.
    He Y; Lin W; Luo J
    Pediatr Hematol Oncol; 2011 Nov; 28(8):708-17. PubMed ID: 22023465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HbF-promoting polymorphisms may specifically reduce the residual risk of cerebral vasculopathy in SCA children with alpha-thalassemia.
    Joly P; Bonello-Palot N; Badens C; Pissard S; Chamouine A; Bernaudin F; Bertrand Y; Connes P; Renoux C
    Clin Hemorheol Microcirc; 2021; 77(3):267-272. PubMed ID: 33216016
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fine-mapping at three loci known to affect fetal hemoglobin levels explains additional genetic variation.
    Galarneau G; Palmer CD; Sankaran VG; Orkin SH; Hirschhorn JN; Lettre G
    Nat Genet; 2010 Dec; 42(12):1049-51. PubMed ID: 21057501
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.